Zimmer Biomet (ZBH) Outlines Strategy to Deliver Above Market Growth
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall St slips on rising bond yields; Walmart results weigh
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
RBC Capital Reiterates Outperform Rating on Zimmer Biomet (ZBH)
May 30, 2024 6:24 AM EDTRBC Capital analyst Shagun Singh reiterated an Outperform rating and $140.00 price target on Zimmer Biomet (NYSE: ZBH)
The analyst comments "ZBH hosted its first investor day today (5/29) at the NYSE, laying out its long-term financial and strategic roadmap. Notably, ZBH expects to deliver... More
Citi Reiterates Neutral Rating on Zimmer Biomet (ZBH)
May 30, 2024 5:38 AM EDTCiti analyst Joanna Wuensch reiterated a Neutral rating and $134.00 price target on Zimmer Biomet (NYSE: ZBH).
The analyst comments "ZBH held its first analyst meeting (ever) today, and while some may question if it can deliver 5-6% organic revenue growth in 2024,... More
